Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora.
Arch Otolaryngol Head Neck Surg. 2005 Sep; 131(9):785-7.AO

Abstract

OBJECTIVE

To compare the effects of cefdinir (14 mg/kg per day) and amoxicillin (90 mg/kg per day) antimicrobial therapy on the nasopharyngeal flora of children with acute otitis media.

DESIGN

Nasopharyngeal cultures for aerobic and facultative bacteria were obtained before therapy and 2 to 4 days after completion of therapy.

SETTING

Outpatient clinic.

PATIENTS

Fifty children, aged 7 months to 5 years 4 months.

MAIN OUTCOME MEASURES

After completion of therapy, 22 (88%) of the 25 patients treated with cefdinir and 16 (64%) of the 25 patients treated with amoxicillin were considered clinically cured (P<.05). A significant reduction in the number of all isolates occurred following therapy in those treated with cefdinir (36 vs 71, P<.01) or with amoxicillin (56 vs 73, P<.05). However, the total number of isolates recovered after therapy was significantly lower in those treated with cefdinir (36) compared with those treated with amoxicillin (56) (P<.01).

RESULTS

The recovery of potential pathogenic organisms (eg, Streptococcus pneumoniae, Staphylococcus aureus, beta-hemolytic streptococci, Haemophilus species, and Moraxella catarrhalis), as well as penicillin-resistant bacteria, was lower following completion of therapy in the cefdinir group (6 pathogens, including 5 that were penicillin resistant), compared with the amoxicillin group (27 pathogens, including 16 that were penicillin resistant) (P<.01).

CONCLUSION

This study illustrates the greater ability of cefdinir compared with amoxicillin to reduce the number of potential nasopharyngeal pathogens as well as penicillin-resistant bacteria in children with acute otitis media.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Brook I
Department of Pediatrics, Georgetown University School of Medicine, Washington, DC, USA. ib6@georgetown.edu
Gober AE
No affiliation info available

MeSH

Acute DiseaseAmoxicillinAnti-Bacterial AgentsAnti-Infective AgentsBacteriaCefdinirCephalosporinsChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleNasopharynxOtitis Media with EffusionRetrospective StudiesTreatment Outcome

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

16172355